OR WAIT null SECS
October 15, 2021
Navigating a complex global regulatory landscape involves upfront research into the expectations of the different regulatory bodies, thorough documentation of every step of the API manufacturing process, and good communication.
Between dosage form versatility, product stability, lack of storage restrictions or need to refrigerate, and an easier means of purification, small-molecule APIs present an appealing market niche.
September 01, 2021
Quotient Sciences is investing £6.3 million ($8.68 million) into their drug substance manufacturing capabilities.
August 19, 2021
Curia plans to expand the site’s commercial capabilities with this move.
August 17, 2021
Biotage’s new facility in Cardiff, UK, will produce lipids using large-scale flash purification.
August 13, 2021
Almac Sciences has signed a manufacturing agreement with Pila Pharma for the production of the API XEN-D0501.
July 12, 2021
UltraBurst has a high disintegration speed, which is for all market segments, from prescriptions to nutraceuticals.
Purisys is now certified for ISO 17025 for testing and calibration laboratories and ISO 17034 for reference material producers
June 23, 2021
Centrient started production at its new statins API manufacturing unit in Toansa, India.
June 03, 2021
Through the acquisition, Aceto can now offer its customers support throughout the drug development process and access to North American manufacturing for APIs and advanced intermediates.